# DiaMedica Therapeutics Inc.: Form 8-K, filed Nov 13, 2023

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2023-11-13
- Accepted by EDGAR: Nov 13, 2023, 16:52 ET
- Period: 2023-11-13
- Accession: 0001437749-23-031669
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774923031669/dmtp20231112_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774923031669/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774923031669/dmtp20231112_8k.htm

Filed Nov 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-031669. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.